Renaissance Technologies
NEOS

Renaissance Technologies’s Neos Therapeutics, Inc NEOS Stock Holding History

Renaissance Technologies’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,076,683
Closed -$673K – 3890
2020
Q4 		$673K Buy
1,076,683
+115,783
+12% +$71.5K ﹤0.01% 2692
2020
Q3 		$510K Buy
960,900
+137,757
+17% +$93.6K ﹤0.01% 2807
2020
Q2 		$564K Buy
823,143
+121,900
+17% +$96.6K ﹤0.01% 2828
2020
Q1 		$526K Buy
701,243
+34,375
+5% +$47.2K ﹤0.01% 2741
2019
Q4 		$1.01M Buy
666,868
+258,706
+63% +$388K ﹤0.01% 2625
2019
Q3 		$604K Buy
408,162
+266,607
+188% +$431K ﹤0.01% 2803
2019
Q2 		$183K Buy
141,555
+34,587
+32% +$63.6K ﹤0.01% 3318
2019
Q1 		$279K Buy
+106,968
New +$251K ﹤0.01% 3116
2016
Q1 		– Sell
-42,500
Closed -$609K – 3600
2015
Q4 		$609K Buy
+42,500
New +$641K ﹤0.01% 2668

Renaissance Technologies's NEOS Position: Q1 2021 in Review

Renaissance Technologies sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 1,076,683 shares — an estimated $673K sold.

Renaissance Technologies first reported a position in NEOS in Q4 2015 and held it in 9 quarters. The position peaked at $1.01M in Q4 2019. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

  • Renaissance Technologies reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
  • Renaissance Technologies sold 1,076,683 Neos Therapeutics, Inc shares in Q1 2021, an estimated $673K.
  • Renaissance Technologies first reported a position in Neos Therapeutics, Inc in Q4 2015 and held it in 9 quarters.
  • Renaissance Technologies's Neos Therapeutics, Inc position peaked at $1.01M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.